Skip Navigation
Skip to contents

ICDM 2025

D--13 TODAY.
2025-10-08
Menu Close

Program details

Home

Program
Program details

Menu View

Oral presentations
Oral presentation 1 Chair(s): Chang-Myung Oh
Thursday 25 September, 16:30~17:50
Room 6
(Grand hall 4, B1F)
None OP1-1
Dharmendra KhatriNims University Rajasthan, Jaipur, India
Epigenetic silencing and glial necroinflammation drive cognitive dysfunction in type 2 diabetes: therapeutic insights from lifestyle and molecular modulation
None OP1-2
Jung Eun NamKaist, Republic of Korea
Serotonin is a novel player in selective hepatic insulin resistance
None OP1-3
Mounikashri SelvakumarAcs Medical College And Hospital, India
Gut Microbiome-Derived metabolites as modulators of pancreatic -Cell function in type 2 diabetes: a metabolomic and transcriptomic integration
None OP1-4
So Bin LeeYonsei University Wonju College of Medicine, Republic of Korea
Combination treatment with a Keap1 modulator and TGF-beta receptor i inhibitor ameliorates metabolic dysfunction-associated steatohepatitis
None OP1-5
Dhanush KodiDr Mgr Educational And Research Institute, India
Cross-Talk between epigenetic aging clocks and metabolic memory in type 2 diabetes: a Multi-Tissue longitudinal study
None OP1-6
Yoojin KimKyung Hee University Hospital At Gangdong, Republic of Korea
Differential mechanisms between PPAR-gamma agonist and SGLT2 inhibitor in MASLD of a Diet-Induced obesity mouse model
Oral presentation 2 Chair(s): Kyu Yeon Hur
Thursday 25 September, 16:30~17:50
Room 7
(Grand hall 5, B1F)
None OP2-1
Soo Jin YunKyung Hee University Medical Center, Republic of Korea
Long-Term diabetes prevention effect of the Korean diabetes prevention study
None OP2-2
Nashuha OmarUniversiti Teknologi Mara, Malaysia
Predicting statin prescription in type 2 diabetes Sub-Clusters group using machine learning: identifying treatment gaps in atherogenic risk management
None OP2-3
Kazuyuki MiyashitaThe University of Osaka Graduate School of Medicine, Japan
Ten-year changes of insulin secretion after pancreas transplantation in patients with type 1 diabetes in Japan
None OP2-4
Raul Jr DuranteInternational Graduate School of Leadership, Philippines
ASSOCIATION OF DYSLIPIDEMIA AND TYPE 2 DIABETES AMONG FILIPINO ADULTS
None OP2-5
Shuzhen BaiPeking University People’s Hospital, China
Characteristics and antidiabetic treatment status of type 2 diabetes patients who did not achieve the glycosylated hemoglobin target after treatment: evidence from iCaReMe China registry study
None OP2-6
Jinyoung KimCollege of Medicine, The Catholic University of Korea, Republic of Korea
Time in range during caloric restriction in patients with early type 2 diabetes and obesity: a CGM-Based prospective study
Oral presentation 3 Chair(s): Byung-Hyun Park
Thursday 25 September, 16:30~17:50
Room 8
(Grand hall 6, B1F)
None OP3-1
Sua LeeDaejeon Eulji Medical Center, Eulji University School of Medicine, Republic of Korea
IMPROVEment of blood glucose control using continuous glucose monitoring in diabetic kidney disease: IMPROVE-DKD study
None OP3-2
Chu LinPeking University People's Hospital, China
The association between glucagon-like peptide 1 receptor-based agonists and the risk of musculoskeletal disorders: a systematic review and meta-analysis of randomized controlled trials
None OP3-3
Bijay SubediSchool of Health And Allied Sciences, Pokhara University, Nepal
Prevalence and biochemical variations: albuminuric diabetic kidney diseases (A-DKD) versus normoalbuminuric diabetic kidney diseases (NA-DKD) among type II diabetic patients in western Nepal
Lee-Ling Lim OP3-4
Lee-Ling LimUniversiti Malaya, Malaysia
Nutritional supplements as monotherapy versus combination therapy for painful diabetic peripheral neuropathy: a systematic review and network meta-analysis
None OP3-5
Altaisaikhan KhasagMongolian National University of Medical Sciences, Mongolia
The burden of diabetes and obesity in Mongolia
None OP3-6
Jung A KimKorea University Anam Hospital, Republic of Korea
Liver-related complications and mortality in type 1 and type 2 diabetes with metabolic dysfunctionassociated steatotic liver disease- a nationwide population-based study in Korea
Oral presentation 4 Chair(s): Kyoung-Ah Kim
Friday 26 September, 08:40~10:00
Room 6
(Grand hall 4, B1F)
None OP4-1
Song WangPeking University People's Hospital, China
External validation and application of a machine learning based model for type 2 diabetes progression (ML-PR) in individuals with prediabetes: a Post-hoc analysis of the DPP and DPPOS cohorts
None OP4-2
Sunshine MirandaAngeles University Foundation, Philippines
ChatGPT-assisted sonogram interpretation for PCOS: a proof-of-concept analysis using the PCOSGen dataset
None OP4-3
Pardeep KumarF H Medical College & Hospital, India
Vascular endothelial growth factor as a biomarker of early liver microangiopathy in adolescents with type 1 diabetes mellitus and Non-Alcoholic fatty liver disease
None OP4-4
Chunhua WuThe Affiliated Wuxi People's Hospital of Nanjing Medical University, China
Android and gynoid fat distribution and prediabetes: a Sex-Specific analysis in a Cross-Sectional study
None OP4-5
Rosa OhSamsung Medical Center, Republic of Korea
Identification of clinically meaningful automatically detected postprandial glucose excursions in individuals with type 1 diabetes using personal continuous glucose monitoring
None OP4-6
Yuan WangPeking University People's Hospital, China
Evaluation of efficacy and safety of oral Small-Molecule GLP-1 receptor agonists: a systematic review and Meta-Analysis
Oral presentation 7 Chair(s): Eu Jeong Ku
Friday 26 September, 12:30~13:30
Room 6
(Grand hall 4, B1F)
None OP7-1
Nazmin FatimaKing George's Medical University, India
Can when you eat, reprogram your genes? impact of Time-Restricted feeding on epigenetic modulation in metabolic disorders
None OP7-2
Soo Yeon JangKorea University Guro Hospital, Republic of Korea
Fatty liver index is a significant predictor of all-cause and cause-specific mortality in prediabetes; a nationwide Population-based study
None OP7-3
Neha MishraKing George's Medical University, India
Delving into the relationship between inflammatory biomarkers and the CAP score among individuals diagnosed with NAFLD.
None OP7-4
Hun Jee ChoeHallym University Dongtan Sacred Hospital, Republic of Korea
Prediabetes phenotypes and trajectories to type 2 diabetes: a 20-Year cohort study in Korea
Oral presentation 10 Chair(s): Ki Woo Kim
Friday 26 September, 15:00~16:20
Room 6
(Grand hall 4, B1F)
None OP10-1
Ellen BudionoSoonchunhyang University, Republic of Korea
Deletion of macrophage Set7 protects obesity-induced hepatic insulin resistance through immune-liver axis remodeling
None OP10-2
Piere Angelo BanalAngeles University Foundation, Philippines
Artificial neural network, multilayer perceptron model-based classification of type 2 diabetes using salivary biochemical markers
None OP10-3
Seho JeongDGIST, Republic of Korea
Proteasomal regulation of hepatic fat accumulation via ubiquitin ligase RNF181 under ER stress responses
None OP10-4
Poojasri Jayabarathi BalamuruganAcs Medical College And Hospital, India
Epitranscriptomic regulation of insulin signaling: role of RNA modifications (m6A, m1A) in diabetes
None OP10-5
Hye-Ryeon PARKKyungil University, Republic of Korea
A study on the demand for approval as internal disability in diseases associated with pancreatic endocrine dysfunction
None OP10-6
Raphael Enrique TiongcoAngeles University Foundation, Philippines
Comparative evaluation of Pc-p27 Protein-Based and Whole-Cell ELISA for detecting antibody responses to prevotella copri: a narrative review of diagnostic applications in type 2 diabetes
Oral presentation 5 Chair(s): Chan-Hee Jung
Friday 26 September, 08:40~10:00
Room 7
(Grand hall 5, B1F)
None OP5-1
Sunhan ShinKyung Hee University Medical Center , Republic of Korea
Adherence to lifestyle modification and risk of type 2 diabetes: from the Korean diabetes prevention study
None OP5-2
Vikas SharmaIdc Reserach Center, India
Telemedicine-Guided DASH diet vs. outpatient care in hypertensive women with gestational diabetes mellitus: a feasibility and efficacy study
None OP5-3
Hansel BandasoUniversitas Sebelas Maret, Indonesia
Clinical outcomes of dysglycemia using continuous glucose monitoring (CGM) in acute ischemic stroke patients: systematic review and Meta-Analysis
None OP5-4
Hyun Sik KimYonsei University Wonju College of Medicine, Republic of Korea
Development of a GLIM (glycemic instability measure) to forecast 12h nocturnal hypoglycemia
None OP5-5
Gayathri SaravananDr. M.g.r. Educational And Research Institute, India
AI-Powered conversational agents for screening and reducing diabetes distress in primary care settings
None OP5-6
Rafik PrabowoCommunity Health Center of Rambah, Rokan Hulu, Indonesia
PROTEIN (protection, prevention, and early detection) is an effective program to prevent metabolic syndrome in rural areas in Indonesia
Oral presentation 8 Chair(s): Eun Roh
Friday 26 September, 12:30~13:30
Room 7
(Grand hall 5, B1F)
None OP8-1
Yan ZhangGwangju Institute of Science And Technology, Republic of Korea
Nicotinamide riboside restores NAD+ levels and prevents ferroptosis in Ritonavir-induced lipodystrophy and multi-organ damage
None OP8-2
Rohit RajputShakuntla Hospital And Research Center,, India
Modulating oxidative stress and renal function in diabetes with gallic acid and probiotics
None OP8-3
Hafizh RizqiPrince Sattam Bin Abdulaziz University, Indonesia
Transcriptomic alterations in visceral adipose tissue associated with type 2 diabetes mellitus
None OP8-4
Nadyatul HusnaDr. Reksodiwiryo Military Hospital Padang, Indonesia
Obesity-Induced transcriptomic alterations and functional impairment in subcutaneous Adipose-Derived stem cells
None OP8-5
Soojung HahnSamsung Medical Center, Republic of Korea
Intestinal Organoid-Derived exosomes attenuate steatohepatitis via metabolic and inflammatory modulation
Oral presentation 11 Chair(s): Sunghwan Suh
Friday 26 September, 15:00~16:20
Room 7
(Grand hall 5, B1F)
None OP11-1
Utari Nur AlifahWelas Asih Regional Hospital of West Java Province, Indonesia
A comparative analysis of machine learning algorithms for predicting large for gestational age in infants of pregnant women with diabetes mellitus
None OP11-2
Jung Yoon MoonAsan Medical Center, University of Ulsan College of Medicine, Republic of Korea
Association between estimated glucose disposal rate and cardiac diastolic dysfunction
None OP11-3
Julie Ann MercadoAngeles University Foundation, Philippines
Association of weather patterns with gestational and type 2 diabetes mellitus prevalence in luzon, Philippines: a multi-year regional analysis
None OP11-4
Han WuPeking University, China
Baseline clinical characteristics in early-onset versus late-onset type 2 diabetes in China: real-world evidence from iCaReMe China registry study
None OP11-5
Ashok SahA’ Sharqiyah University, Oman
Evaluating liver stiffness in type 2 diabetes: implications for NAFLD, chronic kidney disease, and cardiovascular risk
None OP11-6
Reinhard Sadrakh SinabutarRepublic of Indonesia Defense University, Indonesia
Ethnically-based integrated pharmacogenomic mapping of SNP variants relating metformin efficacy in type 2 diabetes mellitus
Oral presentation 6 Chair(s): Hun-Sung Kim
Friday 26 September, 08:40~10:00
Room 8
(Grand hall 6, B1F)
None OP6-1
Chun Ho WongDepartment of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
Impact of diabetes on morbidity, mortality and osteoporosis treatment outcomes in patients with osteoporotic vertebral fractures: insights from prospective vertebral fracture pathway registry
None OP6-2
Kim Sui WanMinistry of Health, Malaysia
The ten-year trend of glycosylated hemoglobin A1c and predictors among 284,106 patients with type 2 diabetes in a multiethnic country in asia: a retrospective open cohort study
None OP6-3
Juan ChenJiangsu Province Hospital of Chinese Medicine, China
Increased lipid accumulation product is associated with decreased urinary glucose excretion in subjects with no history of diabetes: a cross-sectional study
None OP6-4
Nisrina NabilaUniversitas Islam Indonesia, Indonesia
Global, regional, and national burden of type 2 diabetes mellitus, its modifiable factors, and prevalence: an analysis of the global burden of disease study 2021
None OP6-5
So Ra KimYonsei University College of Medicine, Republic of Korea
Protective role of serum beta-hydroxybutyrate in early diabetic kidney disease: a longitudinal study
None OP6-6
Ran GuoThe University of Hong Kong Shen Zhen Hospital, The University of Hong Kong, Hong Kong
Effectiveness of statins for primary prevention and statin associated diabetes progression in patients with type 2 diabetes mellitus and Low-borderline ASCVD risk
Oral presentation 9 Chair(s): Dongryeol Ryu
Friday 26 September, 12:30~13:30
Room 8
(Grand hall 6, B1F)
None OP9-1
Yea Eun KangChungnam National University, Republic of Korea
Heterogeneity of neutrophil subsets and their association with diabetic kidney disease progression: phenotypic and multi-level validation analyses
None OP9-2
Vikas KumarSam Higginbottom University of Agriculture, Technology & Sciences, India
Epigallocatechin Gallate-Loaded pH-Sensitive PEGylated liposomes ameliorate the gestational diabetes mellitus via alteration of PI3K/Akt/mTOR and TLR4/NF-kB/NLRP3 signaling pathway
None OP9-3
Yuri TamuraThe University of Osaka Graduate School of Medicine, Japan
Hepatic ARMC5 promotes MASH through SREBP2-mediated cholesterol biosynthesis
None OP9-4
Dae Ho Lee6Gachon University Gil Medical Center, Gachon University College of Medicine, Republic of Korea
Urinary extracellular vesicle RNA signatures and RIOK3 predict diabetic kidney disease progression
Oral presentation 12 Chair(s): Eun Hee Koh
Friday 26 September, 15:00~16:20
Room 8
(Grand hall 6, B1F)
None OP12-1
Leiluo GengState Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine, The University of Hong Kong, Hong Kong
GLUT1 mediates the therapeutic benefits of FGF21 by facilitating futile lipid cycling in adipose tissues
None OP12-2
Abdelaziz GhanemiUniversity of Quebec At Trois-Rivieres, Canada
Exercise-Induced SPARC protein as a potential exercise substitute with therapeutic perspectives against diabetes and metabolic disorders with sparc KO animals as diabetes model
None OP12-3
Zhaoqian XuPeking University People's Hospital, China
Investigating the causal link between liver fat and hyperglycemia
None OP12-4
Jungsun ParkKorea Advanced Institute of Science And Technology, Republic of Korea
PAX4 R192H variant impairs cell function by disrupting cell identity and compensatory capacity in response to metabolic stress
None OP12-5
Noprada MasuwanMahidol University, Thailand
Treg-Associated polymorphisms in GDM: insights from exome sequencing of BACH2, PRDM1, and CTLA4
None OP12-6
Ayaka UedaThe University of Osaka, Graduate School of Midecine, Japan
A method for the generation of human iPS cell-derived delta cells
Oral presentation 13 Chair(s): Hae Jin Kim
Saturday 27 September, 11:00~12:20
Room 6
(Grand hall 4, B1F)
None OP13-1
Yun Kyung ChoAsan Medical Center, University of Ulsan College of Medicine, Republic of Korea
Comparison of diagnostic criteria for fatty liver disease in assessing subclinical coronary atherosclerosis: a Cross-Sectional study
None OP13-2
Wenfeng YangPeking University People’s Hospital, China
Characterizing pre-heart failure status and its associated factors in patients with type 1 diabetes with ultrasound cardiogram: a cross-sectional study
None OP13-3
Ji-hong ParkKangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Republic of Korea
Differential impact of underweight versus obesity on gastrointestinal cancer mortality in type 2 diabetes: a nationwide Population-Based cohort study
None OP13-4
Qian Qian HoongUniversiti Putra Malaysia, Malaysia
Targeting the worst offenders: Ultra-Processed food subtypes and their cardiovascular risk associations in Multi-Ethnic Asian adults with type 2 diabetes
None OP13-5
Xincheng ZouThe University of Hong Kong, Hong Kong
Association between use of renin-angiotensin system blockers and risk of fragility hip fractures in 0.24 million people with type 2 diabetes: a territory-wide cohort study of Hong Kong
None OP13-6
Na Hyun SongSeoul National University College of Medicine, Republic of Korea
Differential risk factors for type 2 diabetes in obese and Non-Obese adults: a Korean 18-year cohort study
Oral presentation 14 Chair(s): Eugene Han
Saturday 27 September, 11:00~12:20
Room 7
(Grand hall 5, B1F)
None OP14-1
Hyewon YangSeoul National University Hospital, Republic of Korea
Time-Dependent impact of postoperative radiation therapy on insulin secretion after pancreatectomy
None OP14-2
Hui Chin KooTunku Abdul Rahman University of Management And Technology, Malaysia
A longitudinal study: later chronotype with poor sleeping habit are associated with poor glycemia measures and body composition in prediabetic individuals
None OP14-3
Ying WeiAffiliated Beijing Chaoyang Hospital of Capital Medical University, China
Continuous glucose monitoring-based metrics with fixed-dose combination versus co-administered dapagliflozin and metformin in Chinese patients with type 2 diabetes mellitus: an exploratory sub-study of the parallel, interventional, open-label EFFICIENT study
None OP14-4
Xiaopeng LiangThe University of Hong Kong, Hong Kong Baptist University, Hong Kong
Trends in awareness, treatment, and control rates of diabetes among hypertensive patients in US national health and nutrition examination survey (NHANES) 2013-2023
None OP14-5
Hyewon MunBucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Republic of Korea
Trends in Glucagon-like Peptide-1 receptor agonist use and patient characteristics in Korea: a nationwide Claims-based study (2015-2023)
None OP14-6
Cordelia Kheng-May LimFaculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia
How dietitians can make Genetic-Informed decision to optimize glycemic variability derived from Real-Time continuous glucose monitor in type 1 diabetes using whole food approach? a case study
Oral presentation 15 Chair(s): Seung-Hoi Koo
Saturday 27 September, 11:00~12:20
Room 8
(Grand hall 6, B1F)
None OP15-1
Hina ParveenKing George Medical University, India
A circuitous insight: deviling the role of Per- and polyfluoroalkyl substances in inducing oxidative stress for progression of Non-Alcoholic fatty liver disease
None OP15-2
Yang ChenZhongda Hospital, Southeast University, China
The interaction between stellate cells and endothelial cells in islets and its potential mechanism
None OP15-3
Venkatakrishnan KarunanithiDr Mgr Educational and Research Institute, India
mRNA therapeutics for insulin and GLP-1 expression in diabetic patients: a novel Non-Cellular strategy for endogenous hormone restoration
None OP15-4
Shugo SasakiThe University of Osaka Graduate School of Medicine, Japan
Imeglimin, unlike metformin, does not perturb differentiation of human induced pluripotent stem cells towards pancreatic beta-like cells and rather enhances gain in beta cell identity gene sets
None OP15-5
Liang WangGuangdong Provincial People's Hospital, China
Exploring the role of PPP1R3G in regulating the molecular structure of liver glycogen particles
None OP15-6
Manvendra SinghHmfa-Miet, India
Hesperidin-loaded polymeric nanoparticles alleviate diabetes and lipid profile induced by atherosclerosis via regulating fibrosis and TGF/SMAD/MMP2/MMP9/CD36 pathway
KDA 대한당뇨병학회Korean Diabetes Association
  • (04146) 101-2104, Lotte Castle President, 109 Mapo-gu, Seoul, Korea
  • Tel: +82-2-714-9064 | E-mail: diabetes@kams.or.kr
  • Business Registration Number: 106-82-31108 | Name of Representative: Bong-Soo Cha
Congress Secretariat (Planbear)
  • #1108, 220, Gonghang-daero, Gangseo-gu, Seoul(07806), Republic of Korea
  • Tel. +82-2-6953-0582   E-mail: icdm@diabetes.or.kr

copyright© By Korean Diabetes Association.
All rights reserved.
Business Registration Number: 106-82-31108
Name of Representative : Bong-Soo Cha